Transmission of Covid-19 During Clubbing Events in Closed Places
ITOC
1 other identifier
interventional
1,216
1 country
1
Brief Summary
The ITOC study is a cluster randomised, controlled, multicentre trial in Paris region, France. The intervention is an 8-hour indoor clubbing event with no mask wearing, no social distancing, at maximum room capacity. 1,200 healthy volunteers aged 18-49 years and fully vaccinated will be included. Participants are recruited by group of up to 10, to be randomized 2:1 to experimental group (800 volunteers in a venue ) or control group (400 volunteers asked to stay at home). All participants will provide a salivary sample the day of experiment and seven days later. Participants will also answer surveys on the social and psychological impact of lockdown and indoor club closing, attitude towards vaccination, behaviour at risk of COVID-19 transmission during the day of the event (for both groups) as well as follow-up surveys on symptoms that participant may experience. Virological analyses include polymerase chain reaction (PCR) of salivary samples and air of the venue, investigating SARS-CoV-2 PCR.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 17, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 26, 2022
CompletedFirst Submitted
Initial submission to the registry
March 8, 2022
CompletedFirst Posted
Study publicly available on registry
April 5, 2022
CompletedApril 5, 2022
April 1, 2022
1 month
March 8, 2022
April 1, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of positive RT-PCR at day 7
Number of participants in each groups with a positive salivary RT-PCR
Day 7
Secondary Outcomes (9)
Number of SARS-CoV-2 infection cases
Day 5 up to day 10
Number of participants with seasonal respiratory viruses
Day 0 and day 7
Number of symptomatic and asymptomatic respiratory infection
Day 5 to day 10
Number of detected virus in the air
Day 0
Number of mutations, deletions and insertions on the viral genome in participants samples
Day 0 and day 7
- +4 more secondary outcomes
Study Arms (2)
participating to the event
EXPERIMENTALNon partipating to the event
NO INTERVENTIONInterventions
Participate in a club event without a mask, indoors, with vaccinated people.
Eligibility Criteria
You may qualify if:
- Aged between 18 and 49 years old
- Vaccination completed
- People who declared to have no risk factor to severe form for Covid-19 disease
- People who declared not to live in the same place as someone with these risk factors
- People residing in Ile-de-France area
- People affiliated with the the French social security citizen scheme
You may not qualify if:
- Presence of symptoms of COVID in the 2 weeks before the event
- Pregnant woman or woman who declares not having an effective contraception method
- Self identification of medical conditions or comorbidities identified as a proven risk of severe COVID infection
- People living with a person with these risk factors
- Confirmed diagnosis of SARS-CoV-2 within two weeks before the event
- Participants under tutorship or curatorship;
- Underage participants;
- Participants unable to give free and informed consent;
- Participants not affiliated to the French social security citizen scheme: obligation to join a social security scheme or be a beneficiary thereof.
- Participants under legal protection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ANRS, Emerging Infectious Diseaseslead
- Cerballiancecollaborator
- Kappa Santécollaborator
Study Sites (1)
ANRS
Paris, 75013, France
Related Publications (2)
Luong Nguyen LB, Goupil de Bouille J, Menant L, Noret M, Dumas A, Salmona M, Le Goff J, Delaugerre C, Crepey P, Zeggagh J; ITOC Study Group. A Randomized Controlled Trial to Study the Transmission of SARS-CoV-2 and Other Respiratory Viruses During Indoor Clubbing Events (ANRS0066s ITOC Study). Clin Infect Dis. 2023 Dec 15;77(12):1648-1655. doi: 10.1093/cid/ciad603.
PMID: 37795682DERIVEDGoupil de Bouille J, Luong Nguyen LB, Crepey P, Garlantezec R, Dore V, Dumas A, Ben Mechlia M, Tattevin P, Gaudart J, Spire B, Lert F, Yazdanpanah Y, Delaugerre C, Noret M, Zeggagh J. Transmission of SARS-CoV-2 during indoor clubbing events: A clustered randomized, controlled, multicentre trial protocol. Front Public Health. 2022 Nov 4;10:981213. doi: 10.3389/fpubh.2022.981213. eCollection 2022.
PMID: 36438274DERIVED
Study Officials
- STUDY DIRECTOR
Yazdan Yazdanpanah, Pr
ANRS, Emerging Infectious Diseases
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 8, 2022
First Posted
April 5, 2022
Study Start
September 4, 2021
Primary Completion
October 17, 2021
Study Completion
February 26, 2022
Last Updated
April 5, 2022
Record last verified: 2022-04